Immunicon Corporation

Company Information
Address Immunicon Corporation
3401 Masons Mill Rd, Ste 100
Huntingdon Valley, PA, 19006


Information

DUNS:

# of Employees: N/A


Ownership Information

HUBZone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. Gene Expression in Circulating Tumor Cells

    Amount: $1,089,994.00

    DESCRIPTION (provided by applicant): The informed development of new treatments for cancer would be greatly facilitated if tumor cells could be directly sampled at multiple time points following the a ...

    STTRPhase II2005Department of Health and Human Services
  2. Gene Expression in Circulating Tumor Cells

    Amount: $100,000.00

    N/A

    STTRPhase I2003Department of Health and Human Services
  3. Analysis of Circulating Cancer Cells Early in Disease

    Amount: $0.00

    DESCRIPTION: (provided by applicant) The long term objective of this proposal is commercialization of a test for the management of cancer. Imm ...

    SBIRPhase I2001Department of Health and Human Services
  4. Analysis of Circulating Cancer Cells Early in Disease

    Amount: $309,500.00

    DESCRIPTION: (provided by applicant) The long term objective of this proposal is commercialization of a test for the management of cancer. Imm ...

    SBIRPhase II2001Department of Health and Human Services
  5. N/A

    Amount: $100,000.00

    N/A

    SBIRPhase I2000Department of Health and Human Services
  6. BIOPROCESSING USING BIORECEPTOR FERROFLUIDS AND HGMS

    Amount: $383,836.00

    THE LONG-TERM OBJECTIVE IS TO DEVELOP A NEW TECHNOLOGY FOR INDUSTRY SCALE AFFINITY SEPARATIONS EMPLOYING PROPRIETARY BIO- RECEPTOR FERROFLUIDS (BR-FF) IN COMBINATION WITH EXISTING HIGH GRADIENT MAGNET ...

    SBIRPhase II1992Department of Health and Human Services
  7. BIOPROCESSING CELLS FROM BLOOD USING BR-FF AND HGMS

    Amount: $50,000.00

    THE LONG TERM OBJECTIVE IS TO DEVELOP A NEW TECHNOLOGY FOR INDUSTRY SCALE AFFINITY SEPARATIONS EMPLOYING PROPRIETARY BIO-RECEPTOR FERROFLUIDS (BR-FF) IN COMBINATION WITH EXISTING CONTINUOUS HIGH GRADI ...

    SBIRPhase I1991Department of Health and Human Services
  8. BIOPROCESSING USING BIORECEPTOR FERROFLUIDS AND HGMS

    Amount: $50,000.00

    N/A

    SBIRPhase I1991Department of Health and Human Services
  9. FEASIBILITY STUDIES FOR DEVELOPING A NOVEL CLINICAL DEVICE ARE PROPOSED.

    Amount: $50,000.00

    FEASIBILITY STUDIES FOR DEVELOPING A NOVEL CLINICAL DEVICE ARE PROPOSED. THIS DEVICE WHICH WOULD USE IMMUNOLOGICAL AND COMPLEMENT REAGENTS IN CONJUNCTION WITH FILTRATION AND/OR ONE OR MORE MAGNETIC RE ...

    SBIRPhase I1985Department of Health and Human Services
  10. Gene Expression in Circulating Tumor Cells

    Amount: $1,089,990.00

    DESCRIPTION (provided by applicant): The informed development of new treatments for cancer would be greatly facilitated if tumor cells could be directly sampled at multiple time points following the a ...

    SBIRPhase IIDepartment of Health and Human Services

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government